A detailed history of Qsv Equity Investors LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Qsv Equity Investors LLC holds 34,756 shares of SLP stock, worth $1.09 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
34,756
Previous 34,756 -0.0%
Holding current value
$1.09 Million
Previous $1.69 Billion 34.14%
% of portfolio
1.04%
Previous 1.76%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.46 - $50.95 $271,181 - $359,248
-7,051 Reduced 16.87%
34,756 $1.69 Billion
Q1 2024

May 15, 2024

BUY
$37.48 - $44.74 $24,361 - $29,081
650 Added 1.58%
41,807 $1.72 Billion
Q4 2023

Feb 14, 2024

BUY
$33.36 - $45.71 $1.37 Million - $1.88 Million
41,157 New
41,157 $1.84 Billion

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $636M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Qsv Equity Investors LLC Portfolio

Follow Qsv Equity Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsv Equity Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qsv Equity Investors LLC with notifications on news.